financetom
Business
financetom
/
Business
/
Samsara Swings to Fiscal Q4 Adjusted Profit, Revenue Rises; Issues Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Samsara Swings to Fiscal Q4 Adjusted Profit, Revenue Rises; Issues Guidance
Mar 8, 2024 1:53 AM

04:35 AM EST, 03/08/2024 (MT Newswires) -- Samsara (IOT) reported late Thursday it swung to fiscal Q4 adjusted profit of $0.04 per diluted share from a $0.02 loss per share a year earlier.

Analysts polled by Capital IQ expected $0.03 earnings per share.

Revenue for the quarter ended Feb. 3 was $276.3 million, up from $186.6 million a year earlier. Analysts polled by Capital IQ expected $258.3 million.

For fiscal Q1, the company expects to report a breakeven to $0.01 earnings per share on an adjusted basis and revenue of $271 million to $273 million. Analysts polled by Capital IQ are expecting earnings of $0.01 per share and revenue of $272.4 million.

For fiscal year 2025, the company expects adjusted earnings of $0.11 to $0.13 per share and revenue of $1.19 billion to $1.2 billion. Analysts polled by Capital IQ are expecting earnings of $0.12 per share and revenue of $1.2 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Agios Pharmaceuticals Says FDA Accepted Supplemental New Drug Application for Pyrukynd
Agios Pharmaceuticals Says FDA Accepted Supplemental New Drug Application for Pyrukynd
Jan 8, 2025
11:16 AM EST, 01/08/2025 (MT Newswires) -- Agios Pharmaceuticals ( AGIO ) said Wednesday that the US Food and Drug Administration has accepted for review its supplemental new drug application for Pyrukynd, or mitapivat, for the treatment of adult patients with non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia. The company said the application was based on the results of two phase...
Kratos Says Awarded $48 Million Contract to Provide Geolocation Support Services
Kratos Says Awarded $48 Million Contract to Provide Geolocation Support Services
Jan 8, 2025
11:15 AM EST, 01/08/2025 (MT Newswires) -- Kratos Defense & Security Solutions (KTOS) said Wednesday it obtained a $48 million contract to provide geolocation global support services. The work on the contract will be carried out in Colorado Springs, Colorado, according to the technology company. Kratos said it expects the work to be completed by Oct. 31, 2029. Shares of...
Update: G Mining Ventures Q4 Gold Production Reaches 40,147 Ounces
Update: G Mining Ventures Q4 Gold Production Reaches 40,147 Ounces
Jan 8, 2025
11:10 AM EST, 01/08/2025 (MT Newswires) -- (Adds analyst comment and updaters shares.) G Mining Ventures ( GMINF ) on Wednesday said it produced 40,147 ounces of gold in the fourth-quarter. Gold sales reached 39,938 ounces in the final quarter of 2024 and 57,082 ounces in the full year. The company said the difference between gold sold and gold produced...
TriSalus Life Sciences Names James Young as CFO
TriSalus Life Sciences Names James Young as CFO
Jan 8, 2025
11:08 AM EST, 01/08/2025 (MT Newswires) -- TriSalus Life Sciences ( TLSI ) said Wednesday it appointed James Young as chief financial officer, succeeding Sean Murphy, who will continue as chief manufacturing, strategy and business development officer. Young previously served as the company's senior vice president of investor relations and treasurer, the company said. TriSalus said it promoted Richard Marshak...
Copyright 2023-2026 - www.financetom.com All Rights Reserved